StonvexLoading…
StonvexStonvexStonvexCore line items from FNB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $569.00M | $2.33B | $1.74B | $1.14B |
Operating Income | $174.00M | $669.00M | $504.00M | $314.00M |
Net Income | $137.00M | $565.00M | $397.00M | $247.00M |
EPS (Diluted) | $0.38 | $1.56 | $1.09 | $0.68 |
Total Assets | $50.63B | $50.23B | $49.89B | $49.73B |
Total Liabilities | $43.83B | $43.47B | $43.25B | $43.20B |
Cash & Equivalents | $2.66B | $2.50B | $2.41B | $2.43B |
Free Cash Flow OCF − CapEx | $133.00M | $376.00M | $277.00M | $128.00M |
Shares Outstanding | 360.23M | 361.95M | 362.33M | 362.66M |